DXC Technology Company filings document operating results, segment reporting and capital-structure activity for its IT services business. Form 8-K reports furnish quarterly and fiscal results, investor call materials, Regulation FD updates and the company's reporting structure across Consulting & Engineering Services, Global Infrastructure Services and Insurance Services.
Other filings and exhibits record debt financing actions involving DXC Capital Funding DAC, senior note offerings, redemption notices, and NYSE Form 25 removal of listing and registration for the 1.750% Notes due 2026. The disclosures also cover common stock reporting, exhibit treatment and Exchange Act filing status.
DXC Technology Company reported second-quarter fiscal 2027 revenue of $3.034 billion, down 4.0% from $3.161 billion a year earlier, and net income attributable to DXC common stockholders of $24 million versus $36 million. Global Infrastructure Services revenue fell 10.0% and segment profit fell 45.9%; Insurance revenue rose 23.1% to $394 million and segment profit rose 60.7% to $45 million, including a favorable contract modification.
For the first six months, revenue was $6.033 billion versus $6.320 billion, while diluted EPS was $0.89 versus $0.29. Operating cash flow was $635 million and free cash flow was $405 million, compared with $595 million and $337 million; free cash flow included $214 million of cash proceeds related to a TCS litigation judgment and $122 million of tax deposits with the IRS. As of September 30, 2026, liquidity was $4.6 billion, including $1.6 billion of cash and $3.0 billion available under the revolving credit facility. DXC repurchased 12,367,405 shares at an average price of $10.50 during the six-month period.
DXC Technology reported preliminary, unaudited Q2 FY2027 revenue of $3.03 billion, down 4.0% year over year. Adjusted EBIT was $187 million, down 26.4%, with a 6.2% margin; non-GAAP diluted EPS was $0.67, down 20.2%, while GAAP diluted EPS was $0.15. Q2 free cash flow was $91 million versus $240 million a year earlier; first-half free cash flow was $405 million versus $337 million.
Bookings were $2.4 billion, down 10%, with a quarterly book-to-bill ratio of 0.80x. Insurance revenue increased 23.1% to $394 million, while Global Infrastructure Services revenue fell 10.0% to $1.427 billion. DXC repurchased approximately 5.7 million shares for $60 million and acknowledged ongoing discussions regarding a possible sale of its insurance business.
For FY2027, DXC guided to revenue of $11.91 billion to $11.98 billion, adjusted EBIT margin of 5.75% to 6.25%, non-GAAP diluted EPS of $2.25 to $2.50, and free cash flow of ~$600 million. Q3 guidance includes revenue of ~$2.98 billion and non-GAAP diluted EPS of ~$0.55.
DXC Technology Co (DXC) reported that its President, Paul James Taylor, received two equity compensation awards of common stock on September 15, 2026. He was granted 204,280 restricted stock units as a prorated FY27 award and 145,914 restricted stock units as a one-time inducement award. Each RSU converts into one share of common stock upon vesting, and both awards vest in three equal annual installments beginning September 15, 2027.
DXC Technology Co (symbol: DXC) is the issuer of record for a Form 4 filing submitted to the SEC.
DXC Technology Co (DXC) reported an insider tax-withholding transaction by executive Venkataraman Ramanathan, EVP, CES. On August 14, 2026, 14,247 shares of common stock were withheld at $10.79 per share to satisfy tax liabilities arising from the vesting of 28,927 restricted stock units (RSUs). Following this withholding, Ramanathan’s directly held position is 230,688 shares, which the company states includes unvested RSUs.
DXC Technology Co reported that Paul James Taylor is an officer of the company, serving as President, DXC
DXC Technology Co received an amended Schedule 13G from Glenview Capital Management, LLC and Larry Robbins reporting that, as of June 30, 2026, they may be deemed the beneficial owners of 0 shares of DXC common stock. The filing states they hold 0% of the class, with no sole or shared power to vote or dispose of any shares. The shares previously related to accounts of Glenview Capital Master Fund, Ltd. and Glenview Offshore Opportunity Master Fund, Ltd., for which Glenview Capital Management serves as investment manager and Mr. Robbins is Chief Investment Officer. The amendment confirms their current ownership is below 5% of DXC’s outstanding common stock.
American Century entities report a significant ownership position in DXC Technology Company common stock. As of June 30, 2026, American Century ETF Trust reports beneficial ownership of 10,022,365 shares, representing 6.2% of the outstanding common stock. American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each report beneficial ownership of 10,436,267 shares, representing 6.4% of the class, with sole voting and dispositive power over these shares. Various investment company clients and institutional accounts advised by American Century Investment Management have rights to dividends and sale proceeds, but no single client holds more than 5% of the class.
DXC Technology Company received an amended Schedule 13G filing indicating that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander collectively report beneficial ownership of 6,613,586 shares of DXC common stock. This represents 4.1% of the outstanding common stock.
The reporting persons have shared voting power over 6,607,521 shares and shared dispositive power over 6,613,586 shares, with no sole voting or dispositive power reported. The shares are held by entities over which Millennium Management LLC and related investment managers exercise voting control and investment discretion, and the filers state that this should not by itself be construed as an admission of beneficial ownership. The filing also notes that the group now holds ownership of 5 percent or less of the class.
Herzog David L reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology Co director David L. Herzog received a grant of 30,900 restricted stock units (RSUs) representing common stock on August 4, 2026. Each RSU entitles him to one share of common stock and will vest on the earlier of one year from the grant date or the 2027 annual meeting of stockholders, with settlement at vesting or a deferred date if elected.
After this award, Herzog directly holds 147,301 shares of DXC common stock, and this amount includes unvested RSUs.